Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Plos One
|
June 9, 2016
Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma
Witold Wiecek, Helene Karcher
Plos One
|
September 9, 2017
Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma
Billy Amzal, Shuai Fu, Jie Meng, et al.
The AAPS Journal
|
February 22, 2011
From target selection to the minimum acceptable biological effect level for human study: use of mechanism-based PK/PD modeling to design safe and efficacious biologics
Jing Yu, Helene Karcher, Adam L Feire, et al.
American Journal of Ophthalmology
|
June 23, 2022
Anti-Vascular Endothelial Growth Factor Treatment Discontinuation and Interval in Neovascular Age-Related Macular Degeneration in the United States
Sophie J Bakri, Helene Karcher, Steffen Andersen, et al.
Ophthalmology and Therapy
|
November 3, 2022
The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data
Raffael G Liegl, Helene Karcher, Shala Chetty-Mhlanga, et al.
Biophysical Journal
|
January 31, 2006
A coarse-grained model for force-induced protein deformation and kinetics
Helene Karcher, Seung E Lee, Mohammad R Kaazempur-Mofrad, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
August 16, 2023
Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study
Debdulal Chakraborty, Milan Thakkar, Ramesh Venkatesh, et al.
Ophthalmology and Therapy
|
June 22, 2023
Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA
Sophie J Bakri, Marie-Noelle Delyfer, Jakob Grauslund, et al.
Allergy and Asthma Proceedings
|
November 3, 2023
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients
Helene Karcher, Matthias Schoenberger, Tejaswini Rayban, et al.
Contemporary Clinical Trials Communications
|
July 3, 2023
Testing the "RCT augmentation" methodology: A trial simulation study to guide the broadening of trials eligibility criteria and inform on effectiveness
Clementine Nordon, Benoit Sanchez, Mei Zhang, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Plos One
|
June 9, 2016
Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma
Witold Wiecek, Helene Karcher
Plos One
|
September 9, 2017
Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma
Billy Amzal, Shuai Fu, Jie Meng, et al.
The AAPS Journal
|
February 22, 2011
From target selection to the minimum acceptable biological effect level for human study: use of mechanism-based PK/PD modeling to design safe and efficacious biologics
Jing Yu, Helene Karcher, Adam L Feire, et al.
American Journal of Ophthalmology
|
June 23, 2022
Anti-Vascular Endothelial Growth Factor Treatment Discontinuation and Interval in Neovascular Age-Related Macular Degeneration in the United States
Sophie J Bakri, Helene Karcher, Steffen Andersen, et al.
Ophthalmology and Therapy
|
November 3, 2022
The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data
Raffael G Liegl, Helene Karcher, Shala Chetty-Mhlanga, et al.
Biophysical Journal
|
January 31, 2006
A coarse-grained model for force-induced protein deformation and kinetics
Helene Karcher, Seung E Lee, Mohammad R Kaazempur-Mofrad, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
August 16, 2023
Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study
Debdulal Chakraborty, Milan Thakkar, Ramesh Venkatesh, et al.
Ophthalmology and Therapy
|
June 22, 2023
Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA
Sophie J Bakri, Marie-Noelle Delyfer, Jakob Grauslund, et al.
Allergy and Asthma Proceedings
|
November 3, 2023
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients
Helene Karcher, Matthias Schoenberger, Tejaswini Rayban, et al.
Contemporary Clinical Trials Communications
|
July 3, 2023
Testing the "RCT augmentation" methodology: A trial simulation study to guide the broadening of trials eligibility criteria and inform on effectiveness
Clementine Nordon, Benoit Sanchez, Mei Zhang, et al.
Page
of 4